| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.03 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |